Sphingosine 1-Phosphate Receptors in Cerebral Ischemia
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Gaire, B.P. | - |
dc.contributor.author | Choi, Ji Woong | - |
dc.date.available | 2021-03-11T01:40:11Z | - |
dc.date.created | 2020-09-18 | - |
dc.date.issued | 2021-03 | - |
dc.identifier.issn | 1535-1084 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/80372 | - |
dc.description.abstract | Sphingosine 1-phosphate (S1P) is an important lipid biomolecule that exerts pleiotropic cellular actions as it binds to and activates its five G-protein-coupled receptors, S1P1–5. Through these receptors, S1P can mediate diverse biological activities in both healthy and diseased conditions. S1P is produced by S1P-producing enzymes, sphingosine kinases (SphK1 and SphK2), and is abundantly present in different organs, including the brain. The medically important roles of receptor-mediated S1P signaling are well characterized in multiple sclerosis because FTY720 (Gilenya™, Novartis), a non-selective S1P receptor modulator, is currently used as a treatment for this disease. In cerebral ischemia, its role is also notable because of FTY720’s efficacy in both rodent models and human patients with cerebral ischemia. In particular, some of the S1P receptors, including S1P1, S1P2, and S1P3, have been identified as pathogenic players in cerebral ischemia. Other than these receptors, S1P itself and S1P-producing enzymes have been shown to play certain roles in cerebral ischemia. This review aims to compile the current updates and overviews about the roles of S1P signaling, along with a focus on S1P receptors in cerebral ischemia, based on recent studies that used in vivo rodent models of cerebral ischemia. © 2020, Springer Science+Business Media, LLC, part of Springer Nature. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | HUMANA PRESS INC | - |
dc.relation.isPartOf | NeuroMolecular Medicine | - |
dc.title | Sphingosine 1-Phosphate Receptors in Cerebral Ischemia | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000568168000001 | - |
dc.identifier.doi | 10.1007/s12017-020-08614-2 | - |
dc.identifier.bibliographicCitation | NeuroMolecular Medicine, v.23, no.1, pp.211 - 223 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85090552064 | - |
dc.citation.endPage | 223 | - |
dc.citation.startPage | 211 | - |
dc.citation.title | NeuroMolecular Medicine | - |
dc.citation.volume | 23 | - |
dc.citation.number | 1 | - |
dc.contributor.affiliatedAuthor | Gaire, B.P. | - |
dc.contributor.affiliatedAuthor | Choi, Ji Woong | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Cerebral ischemia | - |
dc.subject.keywordAuthor | S1P receptors | - |
dc.subject.keywordAuthor | Sphingosine 1-phosphate | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.